Aggravation of seizure-like events by hydrogen sulfide: Involvement of multiple targets that control neuronal excitability

CNS Neuroscience and Therapeutics

Volumn 20, Issue 5, 2014, Pages 411-419

  Luo, Yi ^a   Wu, Peng Fei ^a,b,c   Zhou, Jun ^a   Xiao, Wen ^a   He, Jin Gang ^a   Guan, Xin Lei ^a   Zhang, Jie Ting ^a   Hu, Zhuang Li ^a,b,c   Wang, Fang ^a,b,c   Chen, Jian Guo ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province   (China)

Author keywords

Epilepsy; Glutamate receptor; Hydrogen sulfide; Seizure; Voltage gated sodium channel

Indexed keywords

4 AMINOPYRIDINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; HYDROGEN SULFIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTETRAZOLE; PILOCARPINE; VOLTAGE GATED SODIUM CHANNEL; AMPA RECEPTOR; POTASSIUM; VOLTAGE GATED SODIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DISEASE EXACERBATION; ELECTROENCEPHALOGRAM; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT; SEIZURE; SODIUM CURRENT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENTORHINAL CORTEX; MAGNESIUM DEFICIENCY; MEMBRANE POTENTIAL; METABOLISM; NERVE CELL; PATCH CLAMP TECHNIQUE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE;

4-AMINOPYRIDINE; ANIMALS; DISEASE MODELS, ANIMAL; ENTORHINAL CORTEX; HYDROGEN SULFIDE; MAGNESIUM DEFICIENCY; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PENTYLENETETRAZOLE; PILOCARPINE; POTASSIUM; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; TISSUE CULTURE TECHNIQUES; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84899063402     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12228     Document Type: Article

References (44)

1. Sander JW. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993;34:1007-1016.
2. Schmidt D, Rogawski MA. New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res 2002;50:71-78.
3. Jacobs MP, Leblanc GG, Brooks-Kayal A, et al. Curing epilepsy: progress and future directions. Epilepsy Behav 2009;14:438-445.
4. De Reuck J, Van Maele G. Status epilepticus in stroke patients. Eur Neurol 2009;62:171-175.
5. Hu LF, Lu M, Hon Wong PT, Bian JS. Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal 2011;15:405-419.
6. Kimura H, Nagai Y, Umemura K, Kimura Y. Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal 2005;7:795-803.
7. Eto K, Asada T, Arima K, Makifuchi T, Kimura H. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun 2002;293:1485-1488.
8. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 2010;9:135-146.
9. Hu LF, Wong PT, Moore PK, Bian JS. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 2007;100:1121-1128.
10. Kida K, Yamada M, Tokuda K, et al. Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal 2011;15:343-352.
11. Tang XQ, Yang CT, Chen J, et al. Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clin Exp Pharmacol Physiol 2008;35:180-186.
12. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 2006;37:889-893.
13. Wong PT, Qu K, Chimon GN, et al. High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide. J Neuropathol Exp Neurol 2006;65:109-115.
14. Ren C, Du A, Li D, Sui J, Mayhan WG, Zhao H. Dynamic change of hydrogen sulfide during global cerebral ischemia-reperfusion and its effect in rats. Brain Res 2010;1345:197-205.
15. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996;16:1066-1071.
16. Tang G, Wu L, Wang R. Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol 2010;37:753-763.
17. Shivanthan MC, Perera H, Jayasinghe S, et al. Hydrogen sulphide inhalational toxicity at a petroleum refinery in Sri Lanka: a case series of seven survivors following an industrial accident and a brief review of medical literature. J Occup Med Toxicol 2013;8:9.
18. Chao D, He X, Yang Y, et al. Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex. Toxicol Sci 2012;128:198-208.
19. Chen YJ, Zhang M, Yin DM, et al. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc Natl Acad Sci USA 2010;107:21818-21823.
20. Kovacs R, Rabanus A, Otahal J, et al. Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J Neurosci 2009;29:8565-8577.
21. Qi J, Wang Y, Jiang M, Warren P, Chen G. Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo. J Physiol 2006;571:605-618.
22. Goodwin LR, Francom D, Dieken FP, et al. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J Anal Toxicol 1989;13:105-109.
23. Warenycia MW, Reiffenstein RJ, Goodwin LR, Dieken FP. Brain sulfide levels in anaesthesia: a comparison with hydrogen sulfide intoxication. Toxicol Lett 1989;47:221-224.
24. Bachiega JC, Blanco MM, Perez-Mendes P, Cinini SM, Covolan L, Mello LE. Behavioral characterization of pentylenetetrazol-induced seizures in the marmoset. Epilepsy Behav 2008;13:70-76.
25. Xu ZH, Wu DC, Fang Q, et al. Therapeutic time window of low-frequency stimulation at entorhinal cortex for amygdaloid-kindling seizures in rats. Epilepsia 2010;51:1861-1864.
26. Holtkamp M, Buchheim K, Elsner M, Matzen J, Weissinger F, Meierkord H. Status epilepticus induces increasing neuronal excitability and hypersynchrony as revealed by optical imaging. Neurobiol Dis 2011;43:220-227.
27. Wahab A, Albus K, Gabriel S, Heinemann U. In search of models of pharmacoresistant epilepsy. Epilepsia 2010;51(Suppl 3):154-159.
28. Higgins GA, Breysse N, Undzys E, et al. Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic property. Psychopharmacology 2010;207:513-527.
29. Hu WW, Fang Q, Xu ZH, et al. Chronic h1-antihistamine treatment increases seizure susceptibility after withdrawal by impairing glutamine synthetase. CNS Neurosci Ther 2012;18:683-690.
30. Baraka AM, Hassab El Nabi W, El Ghotni S. Investigating the role of zinc in a rat model of epilepsy. CNS Neurosci Ther 2012;18:327-333.
31. de Guzman P, Inaba Y, Baldelli E, de Curtis M, Biagini G, Avoli M. Network hyperexcitability within the deep layers of the pilocarpine-treated rat entorhinal cortex. J Physiol 2008;586:1867-1883.
32. Jones RS, Heinemann U. Synaptic and intrinsic responses of medical entorhinal cortical cells in normal and magnesium-free medium in vitro. J Neurophysiol 1988;59:1476-1496.
33. Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics 2007;4:18-61.
34. Strege PR, Bernard CE, Kraichely RE, et al. Hydrogen sulfide is a partially redox-independent activator of the human jejunum Na+ channel, Nav1.5. Am J Physiol Gastrointest Liver Physiol 2011;300:G1105-G1114.
35. Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr 2011;11:56-63.
36. Frasca A, Aalbers M, Frigerio F, et al. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis 2011;43:507-515.
37. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 2000;267:129-133.
38. Hu H, Real E, Takamiya K, et al. Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell 2007;131:160-173.
39. Peers C, Bauer CC, Boyle JP, Scragg JL, Dallas ML. Modulation of ion channels by hydrogen sulfide. Antioxid Redox Signal 2012;17:95-105.
40. Mustafa AK, Sikka G, Gazi SK, et al. Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 2011;109:1259-1268.
41. Russo E, Gitto R, Citraro R, Chimirri A, De Sarro G. New AMPA antagonists in epilepsy. Expert Opin Investig Drugs 2012;21:1371-1389.
42. Naspolini AP, Cocco AR, Villa Martignoni F, et al. Traxoprodil decreases pentylenetetrazol-induced seizures. Epilepsy Res 2012;100:12-19.
43. Han Y, Qin J, Chang X, Yang Z, Bu D, Du J. Modulating effect of hydrogen sulfide on gamma-aminobutyric acid B receptor in recurrent febrile seizures in rats. Neurosci Res 2005;53:216-219.
44. Friedman D, Honig LS, Scarmeas N. Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther 2012;18:285-294.